A Prospective Clinical Study Aimed to Assess the Technical Feasibility of RR2 Wearable Home Care Neuromodulation System
NACompletedINTERVENTIONAL
Enrollment
11
Participants
Timeline
Start Date
January 28, 2021
Primary Completion Date
January 2, 2022
Study Completion Date
January 2, 2022
Conditions
Atrial Fibrillation Recurrence
Interventions
DEVICE
CardiaCareTM RR2
Treatment with CardiaCareTM RR2
Trial Locations (1)
Unknown
Sheba medical center, Ramat Gan
All Listed Sponsors
lead
Ziv HealthCare Ltd.
INDUSTRY
NCT04580953 - A Prospective Clinical Study Aimed to Assess the Technical Feasibility of RR2 Wearable Home Care Neuromodulation System | Biotech Hunter | Biotech Hunter